Additionally, we found that HCC patients with lower mRNA expression levels of METTL3 had a better OS (p = 0.003, Figure 4C), while lower mRNA expression levels of ADARB1 were associated with poorer OS of HCC patients (p = 0.0019, Figure 4F). This evidence concerns the gene METTL3 and hepatocellular carcinoma.